# VA106483 and Alpha Blocker Interaction Study in Elderly Males

> **NCT00879216** · PHASE1 · COMPLETED · sponsor: **Vantia Ltd** · enrollment: 12 (actual)

## Conditions studied

- Nocturia

## Interventions

- **DRUG:** VA106483
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00879216
- **Lead sponsor:** Vantia Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-05
- **Final completion:** 2009-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2009-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00879216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00879216, "VA106483 and Alpha Blocker Interaction Study in Elderly Males". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00879216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*